DIRECT MEASUREMENT OF PROPRANOLOL BIOAVAILABILITY DURING ACCUMULATION TO STEADY-STATE

被引：152

作者：

WOOD, AJJ ^{[1
]}

CARR, K ^{[1
]}

VESTAL, RE ^{[1
]}

BELCHER, S ^{[1
]}

WILKINSON, GR ^{[1
]}

SHAND, DG ^{[1
]}

机构：

[1] VANDERBILT UNIV,SCH MED,DIV CLIN PHARMACOL,NASHVILLE,TN 37232

来源：

关键词：

D O I：

10.1111/j.1365-2125.1978.tb00862.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：345 / 350

页数：6

共 11 条

[1] SENSITIVE GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF PROPRANOLOL IN HUMAN PLASMA
DISALLE, E
BAKER, KM
BAREGGI, SR
WATKINS, WD
CHIDSEY, CA
FRIGERIO, A
MORSELLI, PL
[J]. JOURNAL OF CHROMATOGRAPHY, 1973, 84 (02): : 347 - 353
[2] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487
[3] CONTRIBUTION OF LIVER TO OVERALL ELIMINATION OF PROPRANOLOL
GEORGE, CF
ORME, MLE
BURANAPONG, P
MACERLEAN, D
BRECKENRIDGE, AM
DOLLERY, CT
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (01): : 17 - 27
[4] RATE OF ELIMINATION OF TRACER DOSES OF PHENYTOIN AT DIFFERENT STEADY-STATE SERUM PHENYTOIN CONCENTRATIONS IN EPILEPTIC PATIENTS
HOUGHTON, GW
RICHENS, A
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) : 155 - 161
[5] NIES AS, 1973, J PHARMACOL EXP THER, V184, P716
[6] PATERSON J W, 1970, Pharmacologia Clinica, V2, P127, DOI 10.1007/BF00420338
[7] PESSAYRE D, GASTROENTEROLOGY
[8] CLEARANCE CONCEPTS IN PHARMACOKINETICS
ROWLAND, M
BENET, LZ
GRAHAM, GG
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02): : 123 - 136
[9] SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112
[10] GLC DETERMINATION OF PROPRANOLOL, OTHER BETA-BLOCKING DRUGS, AND METABOLITES IN BIOLOGICAL-FLUIDS AND TISSUES
WALLE, T
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (12) : 1885 - 1891